BioRestorative Therapies, Inc. announced that Edward Field has been appointed as President of the company's brtxDISC Division. He previously served as the Executive Vice President and Chief Operating Officer of Cytomedix, Inc. and President and COO of Aldagen, Inc. He was also the President/CEO of two biotechnology companies focused on the development of therapeutics in the cardiovascular, cancer and respiratory disease areas.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.03 USD | -2.87% | +9.73% | +16.67% |
Jun. 13 | Top Midday Gainers | MT |
Jun. 13 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.67% | 13.74M | |
+15.19% | 121B | |
+19.91% | 114B | |
+8.24% | 23.61B | |
-19.80% | 20.43B | |
-16.19% | 16.55B | |
-13.45% | 16.45B | |
-44.35% | 15.59B | |
+66.67% | 15.19B | |
+2.13% | 13.54B |
- Stock Market
- Equities
- BRTX Stock
- News BioRestorative Therapies, Inc.
- BioRestorative Therapies, Inc. Appoints Edward Field as President of the brtxDISC Division